文献速递骨肌MR

轻中度膝骨关节炎患者关节腔内注射治疗前后软骨变化的形态学与定量参数MRI随访:一项随机安慰剂对照试验

Morphological and Quantitative Parametric MRI Follow-up of Cartilage Changes Before and After Intra-articular Injection Therapy in Patients With Mild to Moderate Knee Osteoarthritis: A Randomized, Placebo-Controlled Trial.
PubMed 文献 · Invest Radiol · 2024-02-28

这项双盲、安慰剂对照、单中心试验将120膝(轻中度骨关节炎,Kellgren-Lawrence 1-3级)随机分配至糖皮质激素、透明质酸、富血小板血浆(PRP)或安慰剂关节腔内注射组,用定量T2、T2*及形态学MRI在基线、3个月和12个月评估软骨改变。12个月时PRP组T2值在4个间室较糖皮质激素组降低、在2个间室较安慰剂组降低;形态学参数各组间无显著变化,且T2/T2*与Kellgren-Lawrence分级、年龄、体质指数或疼痛无相关性。

要点

  • PRP注射后12个月,内侧股骨髁完整区及外侧髁中央部T2值较糖皮质激素组降低,内侧胫骨平台前部和中央部较安慰剂组降低。
  • 糖皮质激素注射后12个月,内侧胫骨平台中央部T2值较安慰剂组降低。
  • 形态学参数(改良Outerbridge分级、软骨下骨髓水肿、软骨下囊肿、骨赘)在3个月和12个月各组间均无显著变化。

核心结论

  • 与糖皮质激素相比,PRP注射对内侧股骨间室软骨质量有长期正面影响,12个月后T2值显著改善;就形态学软骨参数而言,糖皮质激素、PRP或透明质酸注射在短期或长期均未显示优于安慰剂的效果。

研究设计与样本

  • 双盲、安慰剂对照、单中心随机试验,共分析120膝(每组30膝),患者中位年龄60岁(四分位距54.0-68.0岁),入组为Kellgren-Lawrence 1-3级轻中度骨关节炎膝,随机接受糖皮质激素、透明质酸、PRP或安慰剂关节腔内注射,于基线和3、12个月行MRI,由2名读者评估定量T2和T2*时间(毫秒)及形态学参数。

关键影像表现/征象

  • 定量T2和T2*测量读者间信度良好,T2的ICC为0.76(四分位距0.68-0.83),T2*的ICC为0.83(四分位距0.76-0.88)。
  • 12个月T2 mapping在14个间室中的6个显示组间显著变化(P=0.001-0.03)。
  • PRP注射后T2值较糖皮质激素组在4个间室降低(内侧股骨髁完整区及外侧髁中央部)。
  • PRP注射后T2值较安慰剂组在2个间室降低(内侧胫骨平台前部和中央部)。
  • 糖皮质激素注射后T2值较安慰剂组在1个间室降低(内侧胫骨平台中央部)。

诊断标准与关键数值

  • 形态学评估采用改良Outerbridge分级,并记录软骨下骨髓水肿、软骨下囊肿和骨赘。
  • 定量评估采用T2和T2*时间(毫秒),T2读者间ICC为0.76(四分位距0.68-0.83),T2*读者间ICC为0.83(四分位距0.76-0.88)。
  • 3个月时T2和T2*时间均未见显著变化,12个月时T2*时间未见显著变化。
  • T2/T2*时间与Kellgren-Lawrence分级、年龄、体质指数或疼痛无相关性(Spearman ρ,-0.23至0.18)。

临床应用与阅片要点

  • 阅片时可关注12个月随访T2 mapping在内侧股骨髁完整区、外侧髁中央部、内侧胫骨平台前部和中央部的变化,这些间室在原文中显示组间差异。
  • 形态学参数在3个月和12个月各组间均无显著变化,报告时不应据形态学改变判断注射疗效优劣。
  • 原文报告T2/T2*时间与Kellgren-Lawrence分级、年龄、体质指数或疼痛无相关性(Spearman ρ,-0.23至0.18)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: Intra-articular injections are routinely used for conservative treatment of knee osteoarthritis (OA). The detailed comparative therapeutic effects of these injections on cartilage tissue are still unclear.

OBJECTIVE: The aim of this study was to detect and compare knee cartilage changes after intra-articular injection of glucocorticoid, hyaluronic acid, or platelet-rich plasma (PRP) to placebo using quantitative (T2 and T2* mapping) and morphological magnetic resonance imaging parameters in patients with mild or moderate osteoarthritis.

MATERIALS AND METHODS: In a double-blinded, placebo-controlled, single-center trial, knees with mild or moderate osteoarthritis (Kellgren-Lawrence grade 1-3) were randomly assigned to an intra-articular injection with 1 of these substances: glucocorticoid, hyaluronic acid, PRP, or placebo. Cartilage degeneration on baseline and follow-up magnetic resonance imaging scans (after 3 and 12 months) was assessed by 2 readers using quantitative T2 and T2* times (milliseconds) and morphological parameters (modified Outerbridge grading, subchondral bone marrow edema, subchondral cysts, osteophytes).

RESULTS: One hundred twenty knees (30 knees per treatment group) were analyzed with a median patient age of 60 years (interquartile range, 54.0-68.0 years). Interreader reliability was good for T2 (ICC, 0.76; IQR, 0.68-0.83) and T2* (ICC, 0.83; IQR, 0.76-0.88) measurements. Morphological parameters showed no significant changes between all groups after 3 and 12 months. T2 mapping after 12 months showed the following significant ( P = 0.001-0.03) changes between groups in 6 of 14 compartments: values after PRP injection decreased compared with glucocorticoid in 4 compartments (complete medial femoral condyle and central part of lateral condyle) and compared with placebo in 2 compartments (anterior and central part of medial tibial plateau); values after glucocorticoid injection decreased compared with placebo in 1 compartment (central part of medial tibial plateau). No significant changes were seen for T2 and T2* times after 3 months and T2* times after 12 months. No correlation was found between T2/T2* times and Kellgren-Lawrence grade, age, body mass index, or pain (Spearman ρ, -0.23 to 0.18).

CONCLUSIONS: Platelet-rich plasma injection has a positive long-term effect on cartilage quality in the medial femoral compartment compared to glucocorticoid, resulting in significantly improved T2 values after 12 months. For morphological cartilage parameters, injections with glucocorticoid, PRP, or hyaluronic acid showed no better effect in the short or long term compared with placebo.

来源:Invest Radiol,查看原文。版权归原作者所有。

引用

  1. Tschopp M, Pfirrmann CWA, Brunner F, et al. Morphological and Quantitative Parametric MRI Follow-up of Cartilage Changes Before and After Intra-articular Injection Therapy in Patients With Mild to Moderate Knee Osteoarthritis: A Randomized, Placebo-Controlled Trial. Invest Radiol. 2024. PMID: 38421679. doi:10.1097/RLI.0000000000001067

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。